Pan-HER ACL

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePan-HER ACL
Drug Alias NameEGFR-inhibiting dominant negative human growth factor (Molecular Logix)MLX-052001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEpidermal growth factor modulators
TargetsEpidermal growth factor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMolecular Logix Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMolecular Logix Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A